Phosphorylation of Threonine-19 of PSD-95 by GSK-3β is Required for PSD-95 Mobilization and Long-Term Depression
Author(s)
Nelson, Christopher D.; Kim, Myung Jong; Hsin, Honor; Chen, Yelin; Sheng, Morgan
DownloadNelson-2013-Phosphorylation of T.pdf (6.398Mb)
PUBLISHER_POLICY
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
Activity of glycogen synthase kinase-3β (GSK-3β) is required for long-term depression (LTD) via molecular mechanisms that are incompletely understood. Here, we report that PSD-95, a major scaffold protein of the postsynaptic density (PSD) that promotes synaptic strength, is phosphorylated on threonine-19 (T19) by GSK-3β. In cultured rat hippocampal neurons, phosphorylation of T19 increases rapidly with chemical LTD and is attenuated by pharmacologic or genetic suppression of GSK-3β. In organotypic rat hippocampal slices, we find that a nonphosphorylatable PSD-95 mutant (T19A) tagged with photoactivatable green fluorescent protein (PAGFP) shows enhanced stability in dendritic spines versus wild-type PSD-95, whereas the phosphomimetic mutant (PSD-95-T19D) is more readily dispersed. Further, overexpression of PSD-95-T19A, but not WT-PSD-95, impairs AMPA receptor internalization and the induction of LTD. These data indicate that phosphorylation on T19 by GSK-3β destabilizes PSD-95 within the PSD and is a critical step for AMPA receptor mobilization and LTD.
Date issued
2013-07Department
Picower Institute for Learning and MemoryJournal
Journal of Neuroscience
Publisher
Society for Neuroscience
Citation
Nelson, C. D., M. J. Kim, H. Hsin, Y. Chen, and M. Sheng. “Phosphorylation of Threonine-19 of PSD-95 by GSK-3 Is Required for PSD-95 Mobilization and Long-Term Depression.” Journal of Neuroscience 33, no. 29 (July 17, 2013): 12122–12135.
Version: Final published version
ISSN
0270-6474
1529-2401